Active Ingredient(s):Naftifine FDA Approved: * February 29, 1988 Pharm Company: *MERZ PHARMS Category:Antifungal
Naftifine (brand name Exoderil) is an allylamine antifungal drug for the topical treatment of tinea pedis, tinea cruris, and tinea corporis (fungal infections).
Naftifine has triple action: antifungal, antibacterial and anti-inflammatory. Its precise mechanism of action is unknown, but may involve selectively blocking sterol biosynthesis via inhibition of the squalene 2,3-epoxidase enzyme. The half-life is approximately 2–3 days. ...
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion